Using Deep Learning Methods to Analyze Automated Breast Ultrasound and Hand-held Ultrasound Images, to Establish a Diagnosis, Therapy Assessment and Prognosis Prediction Model of Breast Cancer.
NCT ID: NCT04270032
Last Updated: 2022-01-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
10000 participants
OBSERVATIONAL
2020-02-01
2024-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Multi-center Study of Deep Learning AI in Breast Mass
NCT05443672
Using Deep Learning and Radiomics to Diagnose Benign and Malignant Breast Lesions Based on Ultrasound
NCT06069921
Application of Deep-learning and Ultrasound Elastography in Opportunistic Screening of Breast Cancer
NCT03851497
Deep Learning With MRI-based Multimodal-data Fusion Enhanced Postoperative Risk Stratification of Breast Cancer
NCT06546072
Remote Breast Cancer Screening Study
NCT04527510
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
2. Marking ABUS images Three doctors use a semi-automatic method to frame the lesions on the image.
3. Building the model Using the deep learning method to preprocess, analyze and train the marked images, and finally get a model diagnosis, efficacy evaluation and prognosis prediction model of breast cancer.
4. Evaluating the model 1)Self-validation: Analyze the sensitivity, AUC of the breast cancer diagnosis model and the false-positive number on each ABUS volume.
2\) Compared the sensitivity, AUC and the false-positive number with a commercial diagnosis model.
3)To test the screening and diagnostic efficacy of computer-aided diagnosis systems through prospective or retrospective studies.
4)By analyzing the size and characteristics of the lesions after neoadjuvant chemotherapy, and predicting the OS and DFS time, the therapy assessment and prognosis prediction model were evaluated.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
malignant group
women with malignant lesions confirmed by pathology
ABUS and HHUS
Using deep learning method to analyze and extract the features of automated breast ultrasound and hand-held ultrasound images
benign group
women with benign lesions confirmed by pathology or stable in follow-up \> 2 years
ABUS and HHUS
Using deep learning method to analyze and extract the features of automated breast ultrasound and hand-held ultrasound images
normal group
women have normal images with follow up \> 2 years
ABUS and HHUS
Using deep learning method to analyze and extract the features of automated breast ultrasound and hand-held ultrasound images
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ABUS and HHUS
Using deep learning method to analyze and extract the features of automated breast ultrasound and hand-held ultrasound images
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Complete basic information and image data
Exclusion Criteria
2. The image quality is poor;
3. In multifocal breast cancer, the correlation between the tumor in the image and the postoperative pathological examination is uncertain.
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoul National University Bundang Hospital
OTHER
Xidian University
OTHER
Shenzhen University
OTHER
The First Affiliated Hospital of the Fourth Military Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Song Hongping
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hongping Song, MD
Role: PRINCIPAL_INVESTIGATOR
Xijing hospital of The fourth military medical university
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The First Affiliated Hospital of Fourth Military Medical University
Xi'an, Shaanxi, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AI-Breast-US
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.